Building solutions for women with science at the core. 👩🔬
Location: United Kingdom, England, London
Employees: 1-10
Total raised: $2.3M
Founded date: 2021
Investors 2
| Date | Name | Website |
| - | FIRSTPICK | firstpick.... |
| - | Seaside Ve... | seasideven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.02.2024 | Pre-Seed | $2.3M | - |
Mentions in press and media 6
| Date | Title | Description |
| 24.02.2024 | Samphire Neuroscience Revolutionizes Menstrual Health with Nettle Wearable | Samphire Neuroscience, a London-based startup, has raised a whopping $2.3 million in Pre-Seed funding to launch Nettle, a groundbreaking neurostimulation wearable designed to target PMS and menstrual pain. This innovative device aims to pro... |
| 23.02.2024 | Samphire Neuroscience secures $2.3M Pre-Seed to launch menstrual health wearable | This week menstrual health gets a boost as medtech startup Samphire Neuroscience secured $2.3 million in Pre-Seed funding to launch Nettle, a medical-grade neurostimulation wearable. Over 90 per cent of women of reproductive age will experi... |
| 21.02.2024 | Samphire Neuroscience is building a brain stimulating wearable for period pain | It’s a horrible truth that many women simply endure period pain every month — perhaps relying on painkillers or a hot water bottle to relieve stomach cramps. For others, menstrual pain can be inescapably debilitating — to the point where th... |
| 21.02.2024 | London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain | - |
| 15.03.2023 | New Cohort and major partner for Tech4Eva Accelerator | |
| - | Samphire Neuroscience | “Samphire Neuroscience is a neurotechnology company dedicated to maximising the well-being of women during menstruation, fourth trimester, and menopause” |